These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24759153)

  • 1. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
    Silver SM; Schroeder BM; Sterns RH; Rojiani AM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.
    Suzuki H; Sugimura Y; Iwama S; Suzuki H; Nobuaki O; Nagasaki H; Arima H; Sawada M; Oiso Y
    J Am Soc Nephrol; 2010 Dec; 21(12):2090-8. PubMed ID: 21030598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
    Gankam Kengne F; Couturier BS; Soupart A; Decaux G
    Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
    Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
    Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline protects against neurologic complications of rapid correction of hyponatremia.
    Gankam-Kengne F; Soupart A; Pochet R; Brion JP; Decaux G
    J Am Soc Nephrol; 2010 Dec; 21(12):2099-108. PubMed ID: 21051736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia.
    Miyazaki T; Yamamura Y; Onogawa T; Nakamura S; Kinoshita S; Nakayama S; Fujiki H; Mori T
    Endocrinology; 2005 Jul; 146(7):3037-43. PubMed ID: 15831573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.
    Iwama S; Sugimura Y; Suzuki H; Suzuki H; Murase T; Ozaki N; Nagasaki H; Arima H; Murata Y; Sawada M; Oiso Y
    Glia; 2011 Mar; 59(3):452-62. PubMed ID: 21264951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia.
    Dhrolia MF; Akhtar SF; Ahmed E; Naqvi A; Rizvi A
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):558-66. PubMed ID: 24821152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microglia in the pathogenesis of osmotic-induced demyelination.
    Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
    Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating profound hyponatremia: a strategy for controlled correction.
    Sterns RH; Hix JK; Silver S
    Am J Kidney Dis; 2010 Oct; 56(4):774-9. PubMed ID: 20709440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia.
    Baker EA; Tian Y; Adler S; Verbalis JG
    Exp Neurol; 2000 Oct; 165(2):221-30. PubMed ID: 10993682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes are an early target in osmotic demyelination syndrome.
    Gankam Kengne F; Nicaise C; Soupart A; Boom A; Schiettecatte J; Pochet R; Brion JP; Decaux G
    J Am Soc Nephrol; 2011 Oct; 22(10):1834-45. PubMed ID: 21885671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
    Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
    J Neuropathol Exp Neurol; 1996 May; 55(5):594-601. PubMed ID: 8627349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?
    Tzamaloukas AH; Shapiro JI; Raj DS; Murata GH; Glew RH; Malhotra D
    Am J Med Sci; 2014 Nov; 348(5):432-9. PubMed ID: 25247759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic challenges in the management of osmotic demyelination syndrome: A case report of a favorable outcome from a tertiary center.
    Elshafei M; Danjuma MI; Tahir RE
    Medicine (Baltimore); 2020 Jun; 99(24):e20283. PubMed ID: 32541452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.
    Rondon-Berrios H; Sterns RH
    Am J Kidney Dis; 2022 Jun; 79(6):890-896. PubMed ID: 34508830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyponatremia in heart failure: physiopathology and pharmacological approach].
    Robledo GG; Cantillo DS; Comín Colet J
    Endocrinol Nutr; 2010 May; 57 Suppl 2():10-4. PubMed ID: 21130957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.